TrialAIDS research and human retroviruses2022
Immunologic Change over 72 Weeks Following Raltegravir- Versus Efavirenz-Based Therapy in HIV/HCV-Coinfected Individuals in Vietnam.
Cecilia M Shikuma et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.